You can save this article by registering for free here. Or sign-in if you have an account.
A man receives the Pfizer-BioNTech COVID-19 Vaccine at a vaccination center in Nuremberg, southern Germany, on March 18, 2021.Photo by Christof Stache/AFP /Getty Images
Article content
A 62-year-old man’s immune system was studied after he claimed to have received 217 COVID vaccine shots.
Advertisement 2
Story continues below
This advertisement has not loaded yet, but your article continues below.
THIS CONTENT IS RESERVED FOR SUBSCRIBERS ONLY
Subscribe now to read the latest news in your city and across Canada.
Unlimited online access to articles from across Canada with one account.
Get exclusive access to the Toronto Sun ePaper, an electronic replica of the print edition that you can share, download and comment on.
Enjoy insights and behind-the-scenes analysis from our award-winning journalists.
Support local journalists and the next generation of journalists.
Daily puzzles including the New York Times Crossword.
SUBSCRIBE TO UNLOCK MORE ARTICLES
Subscribe now to read the latest news in your city and across Canada.
Unlimited online access to articles from across Canada with one account.
Get exclusive access to the Toronto Sun ePaper, an electronic replica of the print edition that you can share, download and comment on.
Enjoy insights and behind-the-scenes analysis from our award-winning journalists.
Support local journalists and the next generation of journalists.
Daily puzzles including the New York Times Crossword.
REGISTER / SIGN IN TO UNLOCK MORE ARTICLES
Create an account or sign in to continue with your reading experience.
Access articles from across Canada with one account.
Share your thoughts and join the conversation in the comments.
Enjoy additional articles per month.
Get email updates from your favourite authors.
THIS ARTICLE IS FREE TO READ REGISTER TO UNLOCK.
Create an account or sign in to continue with your reading experience.
Access articles from across Canada with one account
Share your thoughts and join the conversation in the comments
His case was documented in The Lancet Infectious Diseases journal, in which researchers from the University of Erlangen-Nuremberg said the man appears to be in good health and has suffered no negative side effects.
“We learned about his case via newspaper articles,” said Dr. Kilian Schober, who works in the university’s microbiology department.
“We then contacted him and invited him to undergo various tests in Erlangen,” Schober added. “He was very interested in doing so.”
Schober and his team were prompted to study the hyper-vaccinated man to test whether overstimulating the immune system with so many vaccines may have destroyed or depleted immune cells, hindering the body’s ability to fight off illness.
Advertisement 3
Story continues below
This advertisement has not loaded yet, but your article continues below.
Article content
Researchers found no evidence of an impaired immune system or that the man had ever been infected with the coronavirus.
“We were able to take blood samples ourselves when the man received a further vaccination during the study at his own insistence,” Schober said.
“We were able to use these samples to determine exactly how the immune system reacts to the vaccination.”
Researchers noted they are not recommending people get so many shots, adding they could not make any conclusions about the safety of taking so much of the vaccine.
“Importantly, we do not endorse hyper-vaccination as a strategy to enhance adaptive immunity.”
They wrote on the university’s website: “Current research indicates that a three-dose vaccination, coupled with regular top-up vaccines for vulnerable groups, remains the favoured approach.”
Postmedia is committed to maintaining a lively but civil forum for discussion. Please keep comments relevant and respectful. Comments may take up to an hour to appear on the site. You will receive an email if there is a reply to your comment, an update to a thread you follow or if a user you follow comments. Visit our Community Guidelines for more information.
This website uses cookies to personalize your content (including ads), and allows us to analyze our traffic. Read more about cookies here. By continuing to use our site, you agree to our Terms of Use and Privacy Policy.
Postmedia is committed to maintaining a lively but civil forum for discussion. Please keep comments relevant and respectful. Comments may take up to an hour to appear on the site. You will receive an email if there is a reply to your comment, an update to a thread you follow or if a user you follow comments. Visit our Community Guidelines for more information.